Preservation and analysis of pathology records and family histories of children with cancerDr John Bithell, University of Oxford
Two radiopharmaceuticals for treatment of neuroblastomaProfessor Anthony Chalmers, University of Glasgow
The developmental history of bilateral neuroblastomaSarah Farndon, UCL Institute of Child Health
Targeting c-MYB in acute leukaemia through drug repositioningDr Katherine Clesham, UCL Institute of Child Health
Immunotherapy for relapsed paediatric acute lymphoblastic leukaemiaProfessor Persis Amrolia, UCL Institute of Child Health, London
One of the greatest medical success stories of the last century is the amazing growth in the survival from childhood cancer. Fifty years ago, only a quarter of children diagnosed with cancer survived. Today, more than 80 per cent of young patients can be successfully treated.
However, cancer still claims the lives of around 250 children every year in the UK. And unfortunately the children who survive may be left with serious health and developmental problems as a result of the intensive treatments used to save their young lives.
Through our investment in research, we are taking forward our understanding of childhood cancer, to give new insights into ways of treating young patients with even the most difficult forms of cancer. We hope to drive up the survival rate still further whilst reducing the risk of harm.